Home > Financial Ratios > CIPLA

CIPLA
Working Capital/Sales

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.502.633.033.293.71

What is the latest Working Capital/Sales ratio of CIPLA ?

The latest Working Capital/Sales ratio of CIPLA is 2.50 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.50
Mar20232.63
Mar20223.03
Mar20213.29
Mar20203.71

How is Working Capital/Sales of CIPLA Trending?

Years Working Capital/Sales % Change
Mar2024 2.5
-4.94
Mar2023 2.63
-13.20
Mar2022 3.03
-7.90
Mar2021 3.29
-11.32
Mar2020 3.71 -

Other Financial Ratios of CIPLA


Compare Working Capital/Sales ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹116,431.7 Cr -5.4% -1.5% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,393.0 Cr -2.8% 7.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹153,258.0 Cr -2.3% 0.8% 72.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,474.0 Cr -0.8% 6.8% 25.6% Stock Analytics
MANKIND PHARMA ₹99,974.0 Cr 2.1% 3.7% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,465.9 Cr -5.5% 1.6% -5.1% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-5.4%

-1.5%

0.8%

SENSEX

0.7%

4%

6.3%


You may also like the below Video Courses